2,5-Dimethoxy-4-cyanoamphetamine

From WikiMD's Medical Encyclopedia

Revision as of 06:36, 5 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Chemical compound


2,5-Dimethoxy-4-cyanoamphetamine
File:DOCN structure.png
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


2,5-Dimethoxy-4-cyanoamphetamine (DOCN) is a psychedelic phenethylamine and a member of the amphetamine class of compounds. It is known for its psychoactive effects and is structurally related to other compounds in the 2,5-dimethoxy family.

Chemical Structure and Properties[edit]

File:DOCN structure.png
Structure of 2,5-Dimethoxy-4-cyanoamphetamine

2,5-Dimethoxy-4-cyanoamphetamine is characterized by the presence of a cyano group at the 4-position of the phenyl ring, along with two methoxy groups at the 2 and 5 positions. The chemical formula is C12H16NO2, and it has a molecular weight of 206.26 g/mol.

The compound is a derivative of amphetamine, with the addition of methoxy groups and a cyano group, which significantly alters its pharmacological properties compared to the parent compound.

Pharmacology[edit]

DOCN acts primarily as a serotonin receptor agonist, similar to other psychedelic amphetamines. It is believed to interact with the 5-HT2A receptor, which is associated with the psychedelic effects of these compounds. The presence of the cyano group may influence its binding affinity and selectivity for various serotonin receptor subtypes.

Effects[edit]

The effects of 2,5-Dimethoxy-4-cyanoamphetamine are not well-documented in scientific literature, but it is presumed to produce effects similar to other psychedelic amphetamines such as 2,5-Dimethoxy-4-iodoamphetamine (DOI) and 2,5-Dimethoxy-4-bromoamphetamine (DOB). These effects may include altered perception, mood changes, and visual hallucinations.

Synthesis[edit]

The synthesis of DOCN involves the introduction of a cyano group to the 4-position of the phenyl ring in the 2,5-dimethoxyamphetamine structure. This can be achieved through various chemical reactions, including the use of cyanide sources in the presence of appropriate catalysts.

Legal Status[edit]

The legal status of 2,5-Dimethoxy-4-cyanoamphetamine varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated psychedelic compounds.

Related Compounds[edit]

See Also[edit]

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.